Newamsterdam Pharma Company N.V. (NAMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NAMS | CNTA | HROW | ||
| Company | Newamsterdam Pharma Company N.V. | Centessa Pharmaceuticals Plc ADR | Harrow Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 18.32 | 15.05 | 44.50 | ||
| High | 18.32 | 15.23 | 44.84 | ||
| Low | 17.03 | 14.48 | 43.59 | ||
| Last | 17.83 | 15.01 | 44.09 | ||
| Change | -0.17 | -0.08 | -0.33 | ||
| % Change | -0.94% | -0.53% | -0.74% | ||
| Volume | 93,313 | 47,835 | 104,608 | ||
| 20-Day Average Volume | 194,446 | 267,966 | 538,750 | ||
| Previous Close | 18.00 | 15.09 | 44.42 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 18.59 | 15.70 | 51.50 | ||
| 20-Day Raw Stochastic | 32.42% | 9.25% | 3.07% | ||
| 20-Day Relative Strength | 50.26% | 48.78% | 43.54% | ||
| Weighted Alpha | +33.26 | +101.49 | +160.99 | ||
| Today's Opinion | 24% Sell | 64% Buy | 56% Buy | ||
| Previous Opinion | 24% Sell | 64% Buy | 56% Buy | ||
| Last Month's Opinion | 56% Sell | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.83% since 10/24/24 | -3.10% since 10/24/24 | -16.91% since 10/24/24 | ||
| Low | 17.15 on 10/31/24 | 14.84 on 10/31/24 | 43.59 on 10/31/24 | ||
| High | 19.30 on 10/28/24 | 15.86 on 10/28/24 | 53.99 on 10/25/24 | ||
| 1-Month | |||||
| %Chg | +8.13% since 09/30/24 | -6.07% since 09/30/24 | -1.98% since 09/30/24 | ||
| Low | 15.51 on 10/01/24 | 14.84 on 10/31/24 | 42.89 on 10/01/24 | ||
| High | 19.93 on 10/24/24 | 17.44 on 10/01/24 | 59.23 on 10/18/24 | ||
| 3-Month | |||||
| %Chg | +10.94% since 07/30/24 | +41.56% since 07/30/24 | +83.47% since 07/30/24 | ||
| Low | 15.19 on 09/25/24 | 9.10 on 08/05/24 | 21.33 on 08/07/24 | ||
| High | 19.93 on 10/24/24 | 17.59 on 09/13/24 | 59.23 on 10/18/24 | ||
| 6-Month | |||||
| %Chg | -17.70% since 04/30/24 | +63.97% since 04/30/24 | +332.48% since 04/30/24 | ||
| Low | 15.19 on 09/25/24 | 7.75 on 05/29/24 | 10.04 on 05/01/24 | ||
| High | 23.01 on 05/02/24 | 17.59 on 09/13/24 | 59.23 on 10/18/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,620,270 | 1,709,908 | 1,576,155 | ||
| Shares Outstanding, K | 90,015 | 113,314 | 35,483 | ||
| Annual Sales | 14,090,000 | 6,850,000 | 130,190,000 | ||
| Annual Net Income | -176,940,000 | -151,090,000 | -24,410,000 | ||
| Last Quarter Sales | 2,280,000 | 0 | 48,940,000 | ||
| Last Quarter Net Income | -39,010,000 | -38,050,000 | -6,470,000 | ||
| 60-Month Beta | 0.00 | 1.46 | 0.75 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.51 on 08/07/24 | -0.40 on 08/13/24 | -0.13 on 08/07/24 | ||
| Latest Earnings Date | 11/06/24 | 11/11/24 | 11/11/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||